John Maris
Chair · St Jude Children's Research Hospital
Credentials: · · ·
History
Research
Review · The Lancet · 2007 · First of 4 authors · Corresponding · 1,824 citations
Recent advances in neuroblastoma
Review · New England Journal of Medicine · 2010 · Sole author · 1,600 citations
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
New England Journal of Medicine · 2010 · 1,404 citations
- MS
87 papers
71 papers
- EK
69 papers
66 papers · 5 as a fellow
56 papers
54 papers · 1 as a fellow
51 papers
49 papers
Grants
- 2017–2032
Discovering Mechanisms of Neuroblastoma Tumorigenesis to Improve Patient Outcomes
National Cancer Institute · R35
Contact PI · $8.7M · Children's Hosp of Philadelphia
- 2017–2029
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
National Cancer Institute · P01
Contact PI · $18.3M · Children's Hosp of Philadelphia
- 2023–2028
Personalized Neuroblastoma Vaccines
National Cancer Institute · U01
Contact PI · $3.4M · Children's Hosp of Philadelphia
- 2022–2027
Clinical trials
- 2016–2022
Next Generation Personalized Neuroblastoma Therapy
Principal investigator · Terminated · Phase 1
Yael P Mosse
- 2010–2016
Biomarkers in Young Patients With Neuroblastoma
Principal investigator · Completed
Children's Oncology Group
- 2006
Principal investigator · Completed
Children's Oncology Group
- 2005–2013
Principal investigator · Completed · Phase 2
New Approaches to Neuroblastoma Therapy Consortium